Assessing the Risk of Relapse After In Vitro Fertilization in Women With Multiple Sclerosis.

Date publication

mars 2025

Journal

Neurology(R) neuroimmunology & neuroinflammation

Auteurs

Membres identifiés du Cancéropôle Est :
Pr DE SEZE Jérôme

Tous les auteurs :
Mainguy M, Casey R, Vukusic S, Lebrun-Frenay C, Berger E, Kerbrat A, Al Khedr A, Bourre B, Ciron J, Clavelou P, De Seze J, Defer G, Doghri I, Dos Santos A, Hankiewicz K, Labauge PM, Le Page E, Magy L, Maillart E, Manchon E, Michel L, Moreau T, Moulin S, Pelletier J, Pottier C, Ruet A, Sarov M, Stankoff B, Thouvenot E, Wahab A, Zephir H, Leray E, Laplaud DA

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39933125

Résumé

Older studies reported an increased risk of relapse after in vitro fertilization (IVF) in women with multiple sclerosis (MS), which has not been confirmed by more recent works. All these studies had several limitations, such as small sample sizes, absence of a control population, or lack of neurologic validation of the relapses. The aim of this study was to determine the risk of relapse after IVF in women with MS.

Mots clés

Humans, Female, Fertilization in Vitro, statistics & numerical data, Adult, Retrospective Studies, Recurrence, Multiple Sclerosis, therapy, France, epidemiology, Registries, Risk Assessment

Référence

Neurol Neuroimmunol Neuroinflamm. 2025 03;12(2):e200371